XORTX Therapeutics, Inc. (XRTX)

1.41 -0.44 (-23.78%) USD  |  NASDAQ  |  Oct 09, 16:00
1.47 +0.06 (+4.26%) After-Hours: 20:00
More

XORTX Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for XRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to . Start Trial.
Date Value

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Lexaria Bioscience Corp. Upgrade
InMed Pharmaceuticals, Inc. Upgrade
Target Group, Inc. (Canada) --
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade